0001562180-17-003383.txt : 20171030 0001562180-17-003383.hdr.sgml : 20171030 20171030170349 ACCESSION NUMBER: 0001562180-17-003383 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171026 FILED AS OF DATE: 20171030 DATE AS OF CHANGE: 20171030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAUMGARTNER ROBERT V CENTRAL INDEX KEY: 0001258704 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 171163112 MAIL ADDRESS: STREET 1: 5775 WAYZATA BOULEVARD, SUITE 400 CITY: MINNEAPOLIS STATE: MN ZIP: 55416 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2017-10-26 false 0000842023 BIO-TECHNE Corp TECH 0001258704 BAUMGARTNER ROBERT V 5775 WAYZATA BOULEVARD, SUITE 400 MINNEAPOLIS MN 55416 true false false false Common Stock 2017-10-26 4 A false 739.00 0.00 A 7712.00 D Stock Option (right to buy) 125.05 2017-10-26 4 A false 3125.00 0.00 A 2027-10-26 Common Stock 3125.00 3125.00 D Stock Option (right to buy) 91.78 2014-10-30 2024-10-30 Common Stock 4000.00 4000.00 D Stock Option (right to buy) 87.39 2013-10-31 2023-10-30 Common Stock 4000.00 4000.00 D Stock Option (right to buy) 87.34 2016-10-29 2025-10-28 Common Stock 4260.00 4260.00 D Stock Option (right to buy) 70.35 2011-10-27 2021-10-26 Common Stock 5000.00 5000.00 D Stock Option (right to buy) 66.90 2012-10-25 2022-10-24 Common Stock 5000.00 5000.00 D Stock Option (right to buy) 63.03 2009-10-29 2019-10-28 Common Stock 5000.00 5000.00 D Stock Option (right to buy) 61.46 2010-10-28 2020-10-27 Common Stock 5000.00 5000.00 D Stock Options (Right to buy) 101.19 2017-10-26 2026-10-26 Common Stock 3985.00 3985.00 D The option vests on the earlier of the one year anniversary of the grant date (10/26/2018) or the date of Bio-Techne 2018 annual meeting of shareholders. /s/ Brenda S. Furlow, attorney in fact for Robert V. Baumgartner pursuant to Power of Attorney filed here with 2017-10-30 EX-24 2 baumgartnerpoa2017.txt BAUMAGARTNERPOA2017 POWER OF ATTORNEY The undersigned hereby constitutes and appoints Brenda S. Furlow, James Hippel, Anna Weispfenning, Melodie R. Rose, Andrew Nick, Sarah Tucher or either of them acting alone, the undersigned's true and lawful attorneys- in-fact and agent with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place and stead, in any and all capacities, to sign any or all Forms 3, Forms 4 and Forms 5 relating to beneficial ownership of securities of Bio-Techne Corporation (the "Issuer"), to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission and to deliver a copy of the same to the Issuer, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all said attorneys-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue thereof. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney shall remain in effect until such time as the undersigned is no longer subject to the provisions of Section 16 of the Securities Exchange Act of 1934 with respect to securities of the Issuer. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 26th day of October, 2017. /s/ Robert V. Baumgartner